Loading…

Down‐regulation of ASY/Nogo transcription associated with progression of adult T‐cell leukemia/lymphoma

Adult T‐cell leukemia/lymphoma (ATLL) is an aggressive form of human leukemia/lymphoma. Although this disease is initiated by infection with human T‐lymphotropic virus type 1 (HTLV‐1), many HTLV‐1 carriers survive for a long period without aggressive illness, suggesting that other factors may play r...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 2006-10, Vol.119 (7), p.1648-1653
Main Authors: Shimakage, Misuzu, Inoue, Nobumasa, Ohshima, Kohichi, Kawahara, Kunimitsu, Oka, Takashi, Yasui, Kazuta, Matsumoto, Kayoko, Inoue, Hirokazu, Watari, Akihiro, Higashiyama, Shinji, Yutsudo, Masuo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adult T‐cell leukemia/lymphoma (ATLL) is an aggressive form of human leukemia/lymphoma. Although this disease is initiated by infection with human T‐lymphotropic virus type 1 (HTLV‐1), many HTLV‐1 carriers survive for a long period without aggressive illness, suggesting that other factors may play roles in the progression of ATLL to an aggressive state. However, the mechanism involved in this progression still remains unclear. Previously, we have reported that ASY/Nogo mRNA was markedly down‐regulated in human small‐cell lung carcinomas, whereas it was expressed in normal tissues and other lung carcinomas, such as adenocarcinoma and squamous cell carcinoma. To understand whether or not ASY/Nogo gene is involved in the progression of ATLL, we examined the expression of ASY/Nogo mRNA in smoldering, chronic and aggressive ATLL, and found that the expression level of ASY/Nogo mRNA was markedly reduced in clinically aggressive ATLL. HTLV‐1 Tax expression was not affected by the down‐regulation of ASY/Nogo mRNA. These results indicate that the ASY/Nogo gene may act as a suppressor against ATLL progression, independent of Tax expression. © 2006 Wiley‐Liss, Inc.
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.22011